Eminence Opens New GMP Cell Culture Media Manufacturing Facility
SUZHOU, China and BOSTON, Sept. 7, 2023 /PRNewswire/ -- Eminence Biotechnology (Suzhou) Co., Ltd. ("Eminence") is delighted to announce that its state-of-the-art facility for the commercial production of cell culture media ("the new facility") is now fully operational.
- SUZHOU, China and BOSTON, Sept. 7, 2023 /PRNewswire/ -- Eminence Biotechnology (Suzhou) Co., Ltd. ("Eminence") is delighted to announce that its state-of-the-art facility for the commercial production of cell culture media ("the new facility") is now fully operational.
- Equipped with cutting-edge vertical pin-milling manufacturing technology and bolstered by world-class utility systems, the new facility adheres to international GMP standards, ISO9001, and ISO13485 regulations.
- It is designed to provide biopharmaceutical companies worldwide with consistently high-quality, batch-to-batch stable cell culture media products.
- Frank Song, Chairman and CEO of Eminence, commented, "From the very beginning, our focus has been firmly set on the field of cell culture media.